Details
Title
CD19 chimeric antigen receptor T-cell therapy in adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia without complete molecular response at 3 months
Author
Yao, Zhenzhen 1
; Gu, Bin 1 ; Chen, Jia 2 ; Xu, Yang 3
; Chen, Feng 1 ; Xue, Shengli 2
; Qiu, Huiying 2 ; Tang, Xiaowen 3
; Han, Yue 3
; Chen, Suning 3 ; Sun, Aining 2 ; Yu, Lei 4 ; Zhang, Yanming 5
; Wu, Depei 6
; Wang, Ying 3
1 National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China (GRID:grid.429222.d) (ISNI:0000 0004 1798 0228)
2 National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China (GRID:grid.429222.d) (ISNI:0000 0004 1798 0228); Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China (GRID:grid.263761.7) (ISNI:0000 0001 0198 0694)
3 National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China (GRID:grid.429222.d) (ISNI:0000 0004 1798 0228); Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China (GRID:grid.263761.7) (ISNI:0000 0001 0198 0694); Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Suzhou, China (GRID:grid.429222.d) (ISNI:0000 0004 1798 0228)
4 Shanghai Unicar-Therapy Bio-medicine Technology Co., Ltd, Shanghai, China (GRID:grid.263761.7)
5 The Affiliated Huai’an Hospital of Xuzhou Medical University and The Second People’s Hospital of Huai’an, Department of Hematology, Huai’an, China (GRID:grid.470132.3)
6 National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China (GRID:grid.429222.d) (ISNI:0000 0004 1798 0228); Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China (GRID:grid.263761.7) (ISNI:0000 0001 0198 0694); Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Suzhou, China (GRID:grid.429222.d) (ISNI:0000 0004 1798 0228); Soochow University, State Key Laboratory of Radiation Medicine and Protection, Suzhou, China (GRID:grid.263761.7) (ISNI:0000 0001 0198 0694)
; Gu, Bin 1 ; Chen, Jia 2 ; Xu, Yang 3
; Chen, Feng 1 ; Xue, Shengli 2
; Qiu, Huiying 2 ; Tang, Xiaowen 3
; Han, Yue 3
; Chen, Suning 3 ; Sun, Aining 2 ; Yu, Lei 4 ; Zhang, Yanming 5
; Wu, Depei 6
; Wang, Ying 3
1 National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China (GRID:grid.429222.d) (ISNI:0000 0004 1798 0228)
2 National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China (GRID:grid.429222.d) (ISNI:0000 0004 1798 0228); Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China (GRID:grid.263761.7) (ISNI:0000 0001 0198 0694)
3 National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China (GRID:grid.429222.d) (ISNI:0000 0004 1798 0228); Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China (GRID:grid.263761.7) (ISNI:0000 0001 0198 0694); Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Suzhou, China (GRID:grid.429222.d) (ISNI:0000 0004 1798 0228)
4 Shanghai Unicar-Therapy Bio-medicine Technology Co., Ltd, Shanghai, China (GRID:grid.263761.7)
5 The Affiliated Huai’an Hospital of Xuzhou Medical University and The Second People’s Hospital of Huai’an, Department of Hematology, Huai’an, China (GRID:grid.470132.3)
6 National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China (GRID:grid.429222.d) (ISNI:0000 0004 1798 0228); Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China (GRID:grid.263761.7) (ISNI:0000 0001 0198 0694); Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Suzhou, China (GRID:grid.429222.d) (ISNI:0000 0004 1798 0228); Soochow University, State Key Laboratory of Radiation Medicine and Protection, Suzhou, China (GRID:grid.263761.7) (ISNI:0000 0001 0198 0694)
Pages
75
Publication year
2023
Publication date
Dec 2023
e-ISSN
20445385
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2811778099
Copyright
© The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.